Pfizer is planning to apply to the FDA in September for emergency authorization of the vaccine for children aged 2 to 11. Moderna is also conducting clinical trials in small kids for its vaccine. The FDA has already approved vaccinating those 12 and older. Currently there are a lot more families willing to volunteer in trials than spaces available in the trials.